Publications

We work hard to attract, retain, and support the most outstanding faculty.

Filter by

Journal of supramolecular structure

Transmembrane interactions and the mechanisms of transport of proteins across membranes.

1978

Authors: Singer SJ, Ash JF, Bourguignon LY, Heggeness MH, Louvard D

Advances in experimental medicine and biology

Parathyroid hormone receptors and stimulation of renal cyclic 3', 5' AMP in vitro: physiological relevance?

1978

Authors: Kugai N, Dorantes L, Nissenson R, Arnaud CD

Experimental cell research

Induction of premature chromosome condensation in CHO cells fused with polyethylene glycol.

1977

Authors: Lau YF, Brown RL, Arrighi FE

Proceedings of the National Academy of Sciences of the United States of America

Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands.

1977

Authors: Bourguignon LY, Singer SJ

Biochimica et biophysica acta

The effect of 1,25-dihydroxyvitamin D-3 on the distribution of alkaline phosphatase activity along the chick intestinal villus.

1977

Authors: Bikle DD, Empson RN, Herman RH, Morrissey RL, Zolock DR

The Johns Hopkins medical journal

Familial cryoglobulinemia.

1977

Authors: Shoback D

The Johns Hopkins medical journal

Clinical-pathological conference.

1977

Authors: Shoback D, Kan JA

The Journal of thoracic and cardiovascular surgery

The impact of coronary artery bypass on late myocardial infarction.

1977

Authors: Ullyot DJ, Wisneski J, Sullivan RW, Gertz EW, Ryan C

Advances in cyclic nucleotide research | Volume 8

Role of cyclic nucleotides in the transport of water and electrolytes.

1977

Authors: Strewler GJ, Orloff J

The Journal of clinical endocrinology and metabolism | Volume 44 of Issue 1

Adriamycin therapy for advanced insulinoma.

1977

Authors: Eastman RC, Come SE, Strewler GJ, Gorden P, Kahn CR

Two patients with advanced metastatic insulinoma are presented. Both failed to respond to streptozotocin and were refractory to other forms of chemotherapy. Therapy with adriamycin (Patient No. 1) and adriamycin plus 5-fluorouracil (Patient No. 2) led to significant decreases in insulin levels or measurable disease and both patients had clinical remissions lasting 5 to 7 months. Adriamycin may be effective in patients with advanced insulinoma unresponsive to conventional chemotherapy.